Breaking the silence: 10 mental health innovators changing the way Europe cares -- TFN
- Bias Rating
- Reliability
25% ReliableLimited
- Policy Leaning
-94% Very Left
- Politician Portrayal
59% Positive
Continue For Free
Create your free account to see the in-depth bias analytics and more.
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates.
Bias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
40% Positive
- Liberal
| Sentence | Sentiment | Bias |
|---|---|---|
Unlock this feature by upgrading to the Pro plan. | ||
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
69% : Back in 2023, Oliva Health secured €5 million in funding led by Molten Ventures, alongside participation from existing investor Stride VC, new backer Alumni Ventures and angel investor Kieran Flanagan, CMO at Zapier.66% : Funds will fuel Meliora Health's US expansion and enhance assessment, intervention, and machine learning-driven clinical research.
63% : The funding round was led by Mutuelles Impact, managed by XAnge, with participation from MMV, HealthCap, Expon, and DVH Ventures.
62% : Its model includes both direct-to-consumer offerings and partnerships with public health systems to expand access to children's and adolescent mental health care.
60% : The acquisition gives Mindler access to National Health Service contracts in England and Scotland.
59% : Neurocare is focused on mental health care in Germany, offering remote therapy and digital mental health tools.
57% : The company secured €11.25 million in seed funding co-led by Kurma Partners, WE Life Sciences, and the French Tech Seed fund managed on behalf of the French government by Bpifrance as part of France 2030, with participation from Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est and Sambrinvest.
56% : Their offerings tend to be digital therapeutic programmes for issues such as depression, anxiety, insomnia, and stress, typically structured courses backed by clinical research.
55% : The round saw participation from AlbionVC, InHealth Ventures, and Autism Impact Fund.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.
